Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

Despite big fall, most fundamentallystrong stocks still remain expensive

2018-02-05 thehindubusinessline
Priya Kansara If you thought that you could buy your favourite stocks after the carnage on Friday wherein Nifty Midcap and Nifty Smallcap had tanked 4 per cent and 6 per cent, respectively, on a single trading session, then here is the bad news. Most stocks, which lost the most on Black Friday, have not been among analysts’ top picks. So, investors have no choice but to keep a long-term view and buy the good stocks or future likely outperformers at expensive valuation. (13-0)

GlaxoSmithKline Pharma Q3 profit up 69% at Rs89 crore

2018-02-02 livemint
New Delhi: Drug firm GlaxoSmithKline Pharmaceuticals on Friday reported a 69.38% rise in its standalone net profit to Rs89.69 crore for the quarter ended December 2017.

GlaxoSmithKline Pharmaceuticals Limited - Press Release

2018-02-02 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

GlaxoSmithKline Pharmaceuticals Limited - Financial Result Updates

2018-02-02 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

WNS Holdings' (WNS) CEO Keshav Murugesh on Q3 2018 Results - Earnings Call Transcript

2018-01-18 seekingalpha
Good morning, and welcome to the WNS Holdings’ Fiscal 2018 Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. After management’s prepared remarks, we will conduct a question-and-answer session, and instructions for how to ask a question will follow at that time. As a reminder, this conference call is being recorded for replay purposes.

GlaxoSmithKline Pharmaceuticals Limited - Trading Window

2017-12-28 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

GSK Pharma Q2 net profit up 32% at Rs 130 cr

2017-10-25 business-standard
Drug firm GlaxoSmithKline Pharmaceuticals on Wednesday reported a 31.83 per cent rise in standalone net profit to Rs 130.32 crore for the second quarter ended September 30, 2017. The company had posted a net profit of Rs 98.85 crore for the corresponding period of the previous fiscal, GlaxoSmithKline Pharmaceuticals said in a filing to BSE.

GlaxoSmithKline profit rises 32% in Q2 led by recovery of inventory levels

2017-10-25 moneycontrol
GlaxoSmithKline Pharmaceuticals on Wednesday posted a 32 percent increase in net profit to Rs 130.3 crore in the second quarter ended September 30, helped by the recovery of inventories in trade channels which were hit by GST rollout.

GlaxoSmithKline Pharmaceuticals Limited - Press Release

2017-10-25 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

GSK Pharma Q2 profit up 32% at Rs130 crore

2017-10-25 livemint
New Delhi: Drug firm GlaxoSmithKline Pharmaceuticals (GSK Pharma) on Wednesday reported a 31.83% rise in standalone net profit to Rs130.32 crore for the second quarter ended 30 September, 2017.

GlaxoSmithKline Pharmaceuticals Limited - Appointment

2017-10-25 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

GlaxoSmithKline Pharma Q2 net up 32% at Rs 130 cr

2017-10-25 thehindubusinessline
Drug firm GlaxoSmithKline Pharmaceuticals today reported a 31.83 per cent rise in standalone net profit to Rs 130.32 crore for the second quarter ended September 30, 2017.

GlaxoSmithKline Pharmaceuticals Limited - Financial Result Updates

2017-10-25 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

MobileHelp(R) Healthcare Appoints Jerriene Cordova as Director of Telehealth Programs, Telehealth

2017-10-16 marketwired
BOCA RATON, FL--(Marketwired - October 16, 2017) - MobileHelp® Healthcare, a leader in mobile Personal Emergency Response System (mPERS) and health management solutions, today announced the appointment of Jerriene Cordova as Director of Telehealth Programs. Ms. Cordova brings more than two decades of experience in developing new markets and building strategic alliances.